Latest Data & Signals Issued
Below are some of the latest signals issued for BioShares Biotechnology Clinical Trials Fund
General
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | 1.516 | 23 days ( -29.67 % | |
| Last Price | $53.04 | -3.34 % | |
Performance History
7 Days
$52.47
$53.04
1.08%
30 Days
$40.67
$53.04
30.40%
12 Mos
$21.53
$53.04
146.33%
|
|||
11/18
Active Buy Signals
|
Specific Signals
| Signal Type | Signal Value | Importance | Data | |
|---|---|---|---|---|
| High / Low | Neutral | Very Low |
$51.80
- $53.64
Position: 67.30% from low / 32.70% from high · Momentum: 4.29% |
|
| Trend - 3 mos | 11.78 % | High | Width: 29.12 % | |
| Pred. range - 3 mos | $47.58 - $61.44 | Low | -10.28 % - 15.85 % | |
| Volume Direction | Sell | High | Volume: 40,498 · Direction: 0 | |
| Pivot Short | Sell | Very Low | Jul 09, 2026 - 2 days | |
| RSI Short Pivot Signal | Buy | Very Low | Jun 03, 2026 - 26 days | |
| Short MA 3 mos | Sell | Low | Jul 09, 2026 - 2 days | |
| Long MA 3 mos | Buy | Medium | Jun 12, 2026 - 19 days | |
| Short/Long MA 3 mos | Buy | Medium | Jun 18, 2026 - 15 days |
| Signal Type | Signal Value | Importance | Data | |
|---|---|---|---|---|
| Trend - 12 mos | 110.24 % | Very High | Width: 27.94 % | |
| Pred. range - 12 mos | $90.36 - $115.60 | High | 70.37 % - 117.97 % | |
| Short MA 12 mos | Buy | Very High | Jun 11, 2026 - 20 days | |
| Long MA 12 mos | Buy | Very High | Jun 11, 2026 - 20 days | |
| Short/Long MA 12 mos | Buy | Very High | Jun 17, 2026 - 16 days | |
| Pivot Long | Sell | Low | Jul 09, 2026 - 2 days | |
| RSI Long Pivot Signal | Sell | Low | Jul 09, 2026 - 2 days | |
| Bollinger | Buy | Medium | Jun 24, 2026 - 12 days | |
| MACD | Buy | High | No Dates Stored For This Signal |
Signals Effectiveness
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Sign In
Buy BBC